Go Pro

Shield Therapeutics (STX) Stock Chart & Stock Price History

Shield Therapeutics logo
GBX 4.91 +0.01 (+0.20%)
As of 08/21/2026 12:13 PM Eastern

Shield Therapeutics Stock Price Performance

5 Day
Performance
+12.31%
1 Month
Performance
-20.81%
3 Month
Performance
-22.56%
Year-To-Date
Performance
-50.90%
1 Year
Performance
-40.48%
5 Year
Performance
-89.03%

STX Stock Chart for Sunday, August, 23, 2026

The Shield Therapeutics (STX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.48%, with a year-to-date return of -50.90%. In the past month, the stock has decreased 20.81%, reflecting recent market activity.

As of the latest close, Shield Therapeutics traded at GBX 4.91 with a market cap of £52.51 million and volume of 1.74 million shares. Five years ago, the stock traded at GBX 44.75, representing a 89.03% decrease over that period. At the time, it had a market cap of £96.61 million and a volume of 655,942 shares. View the advanced STX chart on TradingView.

Receive STX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Shield Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/21/2026GBX 4.90GBX 4.91
+0.20%
GBX 5GBX 4.701.74 million shs£52.51 million
08/20/2026GBX 4.50GBX 4.90
+8.89%
GBX 5.20GBX 4.317.74 million shs£52.41 million
08/19/2026GBX 4.37GBX 4.50
+2.93%
GBX 4.50GBX 4.30330,827 shs£48.13 million
08/18/2026GBX 4.38GBX 4.37
-0.14%
GBX 4.50GBX 4.302.96 million shs£46.76 million
08/17/2026GBX 4.28GBX 4.38
+2.31%
GBX 4.50GBX 4.283.06 million shs£46.82 million
08/14/2026GBX 4.56GBX 4.28
-6.16%
GBX 4.70GBX 4.233.58 million shs£45.77 million
08/13/2026GBX 4.21GBX 4.56
+8.44%
GBX 4.60GBX 4.103.65 million shs£48.77 million
08/12/2026GBX 4.07GBX 4.21
+3.44%
GBX 4.30GBX 3.904.44 million shs£44.97 million
08/11/2026GBX 3.89GBX 4.07
+4.42%
GBX 4.10GBX 3.872.18 million shs£43.48 million
08/10/2026GBX 3.80GBX 3.89
+2.45%
GBX 3.90GBX 3.761.26 million shs£40.64 million
08/07/2026GBX 4GBX 3.80
-5.00%
GBX 4GBX 3.701.15 million shs£41.18 million
08/06/2026GBX 3.90GBX 4
+2.46%
GBX 4.10GBX 3.901.01 million shs£42.78 million
08/05/2026GBX 3.70GBX 3.90
+5.51%
GBX 4.07GBX 3.703.39 million shs£41.75 million
08/04/2026GBX 3.95GBX 3.70
-6.33%
GBX 4GBX 3.704.79 million shs£42.25 million
08/03/2026GBX 3.95GBX 3.95GBX 4GBX 3.842.91 million shs£42.25 million
07/31/2026GBX 4.40GBX 3.95
-10.23%
GBX 4.50GBX 3.9025.96 million shs£42.25 million
07/30/2026GBX 5.65GBX 4.40
-22.12%
GBX 4.70GBX 4.2524.50 million shs£47.06 million
07/29/2026GBX 5.78GBX 5.65
-2.25%
GBX 6GBX 5.601.49 million shs£60.43 million
07/28/2026GBX 5.71GBX 5.78
+1.31%
GBX 6GBX 5.651.40 million shs£61.82 million
07/27/2026GBX 6.01GBX 5.71
-5.07%
GBX 6.30GBX 5.603.65 million shs£61.02 million
07/24/2026GBX 6.20GBX 6.01
-3.06%
GBX 6.40GBX 61.17 million shs£64.28 million
07/23/2026GBX 6.03GBX 6.20
+2.79%
GBX 6.40GBX 6933,534 shs£66.31 million
07/22/2026GBX 6.13GBX 6.03
-1.52%
GBX 6.40GBX 61.22 million shs£64.51 million

This page (LON:STX) was last updated on 8/21/2026 by MarketBeat.com Staff.
From Our Partners